cabozantinib
Drug Details
- Generic Name
- cabozantinib
- Brand Names
- COMETRIQ, CABOMETYX
- Application Number
- NDA203756
- Sponsor
- Exelixis, Inc.
- NDC Codes
- 6
- Dosage Forms
- KIT, TABLET, CAPSULE
- Routes
- ORAL
- Active Ingredients
- CABOZANTINIB S-MALATE
Indications and Usage
1 INDICATIONS AND USAGE COMETRIQ is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC). COMETRIQ is a kinase inhibitor indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC). ( 1 )